Ching-Fa Yao | Chemistry | Best Researcher Award

Prof. Ching-Fa Yao | Chemistry | Best Researcher Award 

Distinguished Professor, at National Taiwan Normal University, Taiwan.

Ching-Fa Yao, Ph.D., is a Distinguished Professor in the Department of Chemistry at National Taiwan Normal University (NTNU). With over three decades of experience, he has significantly contributed to the field of organic chemistry, specializing in synthetic methodologies, green chemistry, and medicinal chemistry. As an influential academic, Dr. Yao has not only advanced research in synthesizing bio-active compounds but also shaped the education of future scientists through his leadership at NTNU. He currently serves as the Coordinator for the Natural Science Division of the Ministry of Education Advisory Team in Taiwan. His work has had a lasting impact on various research areas, including the development of novel organic compounds for medical applications. Dr. Yao’s academic excellence is demonstrated through his numerous publications and prestigious awards, cementing his role as a leading figure in his field. 🌱

Professional Profile

Scopus

Google Scholar

Education 🎓

Dr. Ching-Fa Yao completed his Ph.D. in Organic Chemistry at Iowa State University, USA, in May 1991. Prior to that, he earned his Bachelor of Science in Chemistry from National Taiwan Normal University (NTNU) in 1982. His solid academic foundation laid the groundwork for his groundbreaking contributions to synthetic chemistry. Throughout his career, he has honed his skills and expertise through postdoctoral positions at prestigious institutions, including the Georgia Institute of Technology and Iowa State University. These formative experiences further strengthened his ability to conduct pioneering research, particularly in synthetic methodologies and bio-active compound synthesis. At NTNU, he has continually expanded his knowledge and impact by mentoring graduate students and influencing scientific direction in Taiwan’s academic community. Dr. Yao’s comprehensive academic journey showcases his dedication to chemistry, from student to distinguished professor, with a focus on green chemistry and medicinal chemistry. 📚

Experience  💼

Dr. Ching-Fa Yao has held multiple influential roles throughout his academic career. Since 1999, he has been a professor at National Taiwan Normal University (NTNU), where he also served as the Chair of the Department of Chemistry from 2010 to 2012. His leadership extended beyond academia, as he became the Coordinator of the Natural Science Division for the Ministry of Education Advisory Team in Taiwan in 2012, where he provided guidance on science policy and education. Dr. Yao has also been a pivotal figure in advancing the research output of his department and enhancing collaboration between institutions. His leadership in the field of synthetic chemistry, coupled with his hands-on experience in academia, has earned him a reputation as a dedicated mentor, providing valuable insight into both theoretical and applied aspects of organic chemistry. Through his various roles, Dr. Yao has consistently contributed to shaping the future of science education and research in Taiwan. 🏆

Research Interests 🔬

Dr. Ching-Fa Yao’s research interests lie at the intersection of synthetic chemistry, green chemistry, and medicinal chemistry. He focuses on developing novel synthetic methodologies, particularly those that enhance sustainability in chemical processes. His work in green chemistry aims to create more environmentally friendly approaches to chemical synthesis, reducing waste and energy consumption. Additionally, Dr. Yao is deeply involved in the synthesis of heterocyclic compounds and bio-active molecules, with a particular interest in their potential applications in medicinal chemistry. His research often focuses on creating compounds with therapeutic potential, contributing to advancements in drug discovery. His expertise in synthetic organic chemistry, coupled with his passion for improving human health, has made him a key figure in the development of new chemical entities for medical applications. Dr. Yao’s ability to synthesize complex organic compounds while ensuring minimal environmental impact reflects his commitment to both science and sustainability. 🌍

Award  🏅

Dr. Ching-Fa Yao has received numerous awards in recognition of his outstanding contributions to chemistry and academia. His extensive research in organic synthesis and medicinal chemistry has earned him a reputation as a leader in his field. Among his many honors, he was recognized for his innovative work in green chemistry and synthetic methodologies, earning prestigious accolades from both national and international scientific communities. His leadership in advancing Taiwan’s academic and research landscape, particularly in chemistry, has led to his appointment in prominent roles such as the Coordinator of the Natural Science Division of Taiwan’s Ministry of Education Advisory Team. Dr. Yao’s ability to combine excellence in research with significant contributions to scientific policy has earned him recognition not only as an educator but also as a mentor and thought leader in the field of chemistry. His continued success reflects his enduring influence on both the academic and scientific communities. 🌟

Top Noted Publications  📚

Dr. Ching-Fa Yao has authored and co-authored numerous publications in top-tier journals, showcasing his expertise in organic chemistry, synthetic methodologies, and medicinal chemistry. Some of his most notable publications include “Cascade Reactions of Enone-Tethered Ketones and Aldehydes with Indoles” in Eur. J. Org. Chem. (2025), and “Indole and Coumarin Derivatives Targeting EEF2K in Aβ Folding Reporter Cells” in Journal of Neurochemistry (2025). His research has had a significant impact on the fields of drug discovery and chemical synthesis. He has also collaborated extensively with other scientists to explore new catalytic reactions and therapeutic compounds. Many of his publications have been widely cited, cementing his position as a leading researcher. For a detailed list of his publications, visit Dr. Yao’s Scholar Page. 📖

  1. Indole and Coumarin Derivatives Targeting EEF2K in Aβ Folding Reporter Cells

    • Published in Journal of Neurochemistry (2025). This study focuses on the role of indole and coumarin derivatives in targeting EEF2K (elongation factor 2 kinase) in Aβ (Amyloid Beta) folding reporter cells, likely with implications for neurodegenerative diseases like Alzheimer’s.

  2. Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3

    • Published in International Journal of Molecular Sciences (2024). This article investigates how small molecules can induce autophagic degradation of polyglutamine proteins, potentially beneficial for treating neurodegenerative diseases like Huntington’s disease.

  3. Iodine-Catalyzed Cascade Reaction of 2-Styrylbenzaldehydes with Indoles in the Synthesis of 1H-Indenes via 4π-Electrocyclization

    • Published in Advanced Synthesis and Catalysis (2024). It describes a method for synthesizing 1H-Indenes using iodine as a catalyst in the reaction of 2-styrylbenzaldehydes with indoles.

  4. Pd(ii)-catalyzed Hydroarylations/Hydroalkenylations of Terminal Alkynes: Regioselective Synthesis of Allylic, Homoallylic, and 1,3-Diene Systems

    • Published in Chemical Communications (2024). This paper explores the palladium-catalyzed hydroarylation and hydroalkenylation of terminal alkynes, offering a way to synthesize complex organic molecules.

  5. Iodine-Catalyzed Regioselective Synthesis of Diphenyl-Substituted Carbazoles via [4 + 2] Annulation of β-Formyl Ketones with Indoles

    • Published in Journal of Organic Chemistry (2023). It presents a strategy for synthesizing diphenyl-substituted carbazoles through an iodine-catalyzed reaction.

  6. Pd-Catalyzed Regioselective (Markovnikov) Addition of Aryl Boronic Acids to Terminal Alkynes of 1,3-Dicarbonyl Compounds and Cyclization/Debenzoylation of Olefinic Dicarbonyl: Access to Arylated Pyran and (E)-4-Methylene-1,6-diphenylhex-5-en-1-one

    • Published in Organic Letters (2023). This research looks into the regioselective addition of aryl boronic acids to alkynes and its applications in the synthesis of aromatic and heterocyclic compounds.

  7. Synthesis of Isoindolo [1,2-b]quinazolin-12(10H)-one by Double Ullman Reaction of 2-Iodobenzamides with Copper Cyanide under Microwave Irradiation

    • Published in ChemistrySelect (2023). This paper reports a microwave-assisted synthesis of isoindoloquinazolinone derivatives using a double Ullman reaction.

  8. One-Pot Knoevenagel/Imination/6π-Azaelectrocyclization Sequence for the Synthesis of Disubstituted Nicotinonitriles

    • Published in Journal of Organic Chemistry (2023). It discusses a one-pot synthetic route to nicotinonitrile derivatives, involving multiple reaction steps.

  9. Iodine-Catalyzed Annulation Reaction of Ortho-Formylarylketones with Indoles: A General Strategy for the Synthesis of Indolylbenzo[b]carbazoles

    • Published in Journal of Organic Chemistry (2023). This research explores a new approach to synthesizing indolylbenzo[b]carbazoles through an iodine-catalyzed annulation reaction.

  10. Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease

  • Published in International Journal of Molecular Sciences (2023). This article investigates the potential therapeutic benefits of indole derivatives in reducing inflammation and oxidative stress in Parkinson’s disease models.

Conclusion

Dr. Ching-Fa Yao’s comprehensive expertise, innovative methodologies, and substantial contributions to chemistry and medicinal research make him an excellent candidate for the “Best Researcher Award.” His work not only advances scientific knowledge but also has tangible benefits for society, particularly in drug discovery and therapeutic development. His leadership in academic settings and his ongoing contributions to the field of synthetic chemistry underline his eligibility for such an esteemed award.

Dr. Srikant Bhagat | Synthetic | Best Researcher Award | 3529

Dr. Srikant Bhagat | Synthetic | Best Researcher Award

Scientist at NAtional Institute , India

A seasoned medicinal chemist with over 20 years of experience,Dr. Srikant Bhagat has contributed extensively to synthetic, medicinal, and analytical chemistry. Holding a Ph.D. from NIPER, Punjab, they specialize in organophosphorus chemistry, SAR studies, and lead optimization. [Name] has spearheaded the design and synthesis of novel heterocycles and NCEs targeting various diseases, including anti-cancer, anti-diabetic, and anti-infective applications. As a Scientist (Grade I) at NIPER, they mentor students, conduct research, and manage laboratory operations. Their work emphasizes green synthesis methodologies and rational drug design.

Publication Profile

scholar

🎓 Education 

Ph.D. in Medicinal Chemistry (2009): NIPER, Punjab (CGPA 9.31/10) – Focus on α-Aminophosphonates and α-Hydroxyphosphonates synthesis.PG Diploma in Chemoinformatics (2004): Institute for Chemoinformatics Studies, Noida – A+ Grade.M.Sc. Chemistry (1996): T. M. Bhagalpur University – 1st Class, Major in Organic Chemistry.B.Sc. Chemistry (1994): T. M. Bhagalpur University – 1st Class, Major in Chemistry.

💼 Experience 

Scientist (Grade I): NIPER, Mohali (2011 – Present)Research Adviser: Unimark Remedies Ltd. (2010 – 2012)Scientist (Grade II): NIPER, Mohali (2006 – 2011)Technical Assistant: NIPER, Mohali (1997 – 2004)

🏅 Awards and Honors 

Awarded prestigious fellowships and grants for advancing medicinal chemistry.Keynote speaker at international symposiums on drug discovery.Recognized for contributions to green chemistry and API development.Honored by NIPER for mentoring and academic excellence.

🔍 Research Focus 

Design and synthesis of organophosphorus compounds and heterocycles.Green methodologies for API development.Novel anti-cancer, anti-tuberculosis, and anti-inflammatory agents.Database generation for drug discovery and combinatorial chemistry.

Publications 📖

Kabachnik–Fields Reaction (2007)

Efficient synthesis of α-aminophosphonates using aldehydes/ketones, amines, and phosphites.

Published in The Journal of Organic Chemistry.

Citations: 389

Magnesium Perchlorate Catalysis (2004)

Catalyst for imines and phenylhydrazones synthesis.

Tetrahedron Letters.

Citations: 248

Zirconium (IV) Catalysis (2008)

Efficient α-aminophosphonates synthesis.

The Journal of Organic Chemistry.

Citations: 180

Protic Acid on Solid Supports (2013)

Enhanced catalytic synthesis of thiazolidin-4-ones.

Green Chemistry.

Citations: 136

Microwave-Assisted Benzothiazoles (2004)

Direct condensation of carboxylic acids with 2-aminothiophenol.

Synlett.

Citations: 118

LiOH·H2O as Catalyst (2006)

Claisen–Schmidt condensation for diaryl-2-propenones.

Journal of Molecular Catalysis A: Chemical.

Citations: 111

 

Conclusion

The candidate’s extensive experience, innovative contributions to synthetic and medicinal chemistry, and leadership in academia and industry make them a strong contender for the Best Researcher Award. Highlighting specific publications, patents, and funding achievements can further bolster their nomination, enhancing the overall presentation of their scientific excellence.

levent dirikolu | Pharmacology and Analytical Chemistry | Best Researcher Award

Prof. levent dirikolu | Pharmacology and Analytical Chemistry | Best Researcher Award

Prof. Louisiana State University, United States

Levent Dirikolu is a distinguished Professor of Pharmacology at Louisiana State University, with a DVM from Ankara University and advanced degrees in Veterinary Science and Pharmacology from the University of Kentucky. His research focuses on pharmacokinetics, pharmacodynamics, toxicokinetics, and drug metabolism. Notably, he has led significant projects on drug testing, including funding from the Louisiana State Racing Commission and ongoing research on anti-glioblastoma compounds. Dirikolu’s honors include multiple Pfizer Research Excellence Awards and a Distinguished Faculty Service Award from LSU. His contributions span comparative pharmacokinetics and drug design, with recent studies on pioglitazone for cats and lomustine for canine lymphoma, among others.

 

Professional Profiles:

Personal Statement🔬

My laboratory focuses on pharmacokinetics, pharmacodynamics, toxicokinetics, and molecular, clinical, and analytical pharmacology/toxicology. I have been involved in various clinical pharmacology studies investigating the safety, efficacy, PK, and PD of new drugs using animal models. With advanced training in PK modeling and analytical pharmacology/toxicology, I am well-positioned to lead research on “New anti-glioblastoma metabolic compounds with high potential for Blood Brain Barrier penetration.”

B. Ongoing Projects

Stanton Foundation: Mitigating Treatment Costs for Addison’s Disease in DogsPI: Daniel K. Langlois, Co-Is: Levent Dirikolu et al.Period: Dec 20, 2022 – presentFunding: $65,492Louisiana State Racing Commission: Drug TestingPI: Levent DirikoluPeriods:July 1, 2020 – June 30, 2021: $1,442,233July 1, 2021 – June 30, 2022: $1,389,185July 1, 2022 – June 30, 2023: $1,450,000

C. Positions and Honors

Positions and Employment2024-present: Director, Center for Clinical Innovation, LSU SVM, Baton Rouge, LA.2016-present: Professor, LSU SVM, Baton Rouge, LA.2013-2015: Associate Professor, University of Illinois, CVM, Urbana, IL.2007-2013: Assistant Professor, University of Illinois, CVM, Urbana, IL.2003-2006: Assistant Professor, Tuskegee University, CVM, Tuskegee, AL.2001-2002: Post-doctoral Fellow, University of Kentucky, Lexington, KY.Other Experience and Professional Memberships2003-present: American Veterinary Medical Association (AVMA)2007-present: American Academy of Veterinary Pharmacology and Therapeutics2003-2006: Director, Core Laboratory, Tuskegee University, CVMNAH, Tuskegee, AL.

Honors

1992: Graduated with honors from Ankara University School of Veterinary Medicine (fourth best student).1997: Honor student program at the University of Kentucky for M.V.Sc (GPA: 3.903).2003: Involved in developing the first FDA-approved therapeutic medications for Equine Protozoal Myeloencephalitis.2005: Faculty performance award, Tuskegee University, College of Veterinary Medicine.2005: Norden Distinguished Teacher of The Year award, Tuskegee University, College of Veterinary Medicine.2006: Pfizer Animal Health Research Excellence Award, Tuskegee University, College of Veterinary Medicine.2008: Arnold O. Beckman Research Award, University of Illinois, College of Veterinary Medicine.2011: CVM Dr. Erwin Small Teaching Excellence Award in Veterinary Medicine, University of Illinois.2011: Pfizer Research Excellence Award, University of Illinois, College of Veterinary Medicine.2012: Dr. Erwin Small Teaching Excellence Award in Veterinary Medicine, University of Illinois.2023: Distinguished Faculty Service Award, Louisiana State University, School of Veterinary Medicine.

D. Contribution to Science

My research spans comparative pharmacokinetics, pharmacodynamics, toxicokinetics, and drug metabolism. I aim to establish a globally recognized pharmacology program focused on the safety and efficacy of investigational new drugs. My expertise facilitates the translation of research findings to clinical applications and the use of human medicines in animal health. Future goals include expanding collaboration within the veterinary college and securing extramural funding.Examples of Studies:

Investigation of Pioglitazone for Diabetes and Hepatic Lipidosis in CatsResearch on the efficacy of pioglitazone for treating diabetes and hepatic lipidosis in cats.Key Publications:Clark M, Hoenig M, Ferguson D, Dirikolu L. Pharmacokinetics of pioglitazone in lean and obese cats. J. Vet. Pharmacol. Ther. 2012.Clark M, Thomaseth K, Dirikolu L, Ferguson DC, Hoenig M. Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats. JVIM, 2014.Pharmacokinetics and Cytotoxicity of Lomustine in DogsExamined lomustine’s pharmacokinetics and toxicity in dogs with lymphoma.Key Publications:Chakkath T, Lavergne SN, Fan TM, Bunick D, Dirikolu L. Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites in Canine Cells. Vet. Sci. 2015.Dirikolu L, McFadden ET, Ely KJ, ElkHoly H, Lehner AF, Thompson K. Clonidine in the horse: Its identification, detection, and clinical pharmacology. Vet. Ther., 2006.Drug Discovery and Design ResearchCollaboration on PK parameters of PAC-1 and other investigational drugs in mouse and dog models.Key Publications:Botham RC, Fan TM, Im I, Borst LB, Dirikolu L, Hergenrother PJ. Dual Small-Molecule Targeting of Procaspase-3. J Am Chem Soc. 2014.Garrett EF, Dirikolu L, Grover GS. Milk and serum concentration of ceftiofur following intramammary infusion in goats. J Vet Pharmacol Ther. 2015.

Evaluation for Best Researcher Award: Levent Dirikolu

Strengths for the Award:

  1. Extensive Expertise and Research Impact:
    • Dr. Levent Dirikolu’s extensive background in pharmacology and toxicology is demonstrated through his research in pharmacokinetics, pharmacodynamics, toxicokinetics, and drug metabolism. His work spans various species and includes both clinical and analytical pharmacology, showcasing a broad and deep understanding of his field.
  2. High-Impact Research and Publications:
    • His significant contributions are evidenced by numerous publications in reputable journals, including high-impact studies on drugs such as pioglitazone, lomustine, and diclazuril. These studies not only advance scientific knowledge but also address practical issues in veterinary medicine, highlighting his research’s real-world applications.
  3. Successful Grant Acquisition and Ongoing Projects:
    • Dr. Dirikolu has secured substantial funding for critical projects, such as drug testing for the Louisiana State Racing Commission and research on mitigating treatment costs for Addison’s Disease in dogs. This track record of successful grant acquisition demonstrates his ability to secure and manage large-scale research projects effectively.
  4. Recognition and Honors:
    • His achievements have been acknowledged through various awards, including the Pfizer Research Excellence Award and the Distinguished Faculty Service Award. These accolades reflect his outstanding contributions to research and teaching in veterinary pharmacology.
  5. Leadership and Professional Service:
    • As the Director of the Center for Clinical Innovation at LSU and a member of professional organizations like the American Veterinary Medical Association and the American Academy of Veterinary Pharmacology and Therapeutics, Dr. Dirikolu’s leadership and service further underscore his commitment to advancing his field.

Areas for Improvement:

  1. Broader Interdisciplinary Collaboration:
    • While Dr. Dirikolu has a strong foundation in veterinary pharmacology, expanding his collaborative efforts to include more interdisciplinary research could enhance the scope and impact of his work. Collaborating with researchers in related fields like human medicine or advanced molecular biology could provide new insights and applications.
  2. Increased Focus on Emerging Areas:
    • Incorporating emerging research areas such as personalized medicine or the use of advanced technologies (e.g., machine learning in pharmacokinetic modeling) could further strengthen his research program. Staying at the forefront of these trends could enhance his contributions and relevance in the field.

 

✍️Publications Top Note :

A review of current chemistry, pharmacology, and regulation of endogenous anabolic steroids testosterone, boldenone, and nandrolone in horses”

Journal: Journal of Veterinary Pharmacology and Therapeutics

Date: July 2023

DOI: 10.1111/jvp.13397

ISSNs: 0140-7783, 1365-2885

Contributors: Levent Dirikolu, Andreas F. Lehner

“Total Carbon Dioxide (TCO2) Concentrations in Thoroughbred and Quarter Racehorses in Louisiana”

Journal: Journal of Equine Veterinary Science

Date: January 6, 2023

DOI: 10.1016/j.jevs.2023.104220

ISSN: 0737-0806

Contributors: Levent Dirikolu, Pamela Waller, Kesha Malveaux, Cam H. Lucas, Izabela Lomnicka, Ashley Pourciau, Hayat Bennadji, Chin-Chi Liu

“Guanabenz in the horse – A preliminary report on clinical effects and comparison to clonidine and other alpha-2 adrenergic agonists”

Journal: Pferdeheilkunde Equine Medicine

Date: 2022

DOI: 10.21836/pem20220607

ISSN: 0177-7726

Contributors: Levent Dirikolu, A F Lehner, L Dirikolu, T Tobin

“Simultaneous quantification of caffeine and its main metabolites by gas chromatography mass spectrometry in horse urine”

Journal: Biomedical Chromatography

Date: October 2022

DOI: 10.1002/bmc.5445

ISSNs: 0269-3879, 1099-0801

Contributor: Levent Dirikolu

“Plasma concentrations of diclazuril following oral administration of diclazuril and diclazuril sodium salt to cattle”

Journal: Journal of Veterinary Pharmacology and Therapeutics

Date: July 2022

DOI: 10.1111/jvp.13062

ISSNs: 0140-7783, 1365-2885

Contributor: Levent Dirikolu

“The medication violations in racehorses at Louisiana racetracks from 2016 to 2020”

Journal: Veterinary Medicine and Science

Date: January 6, 2022

DOI: 10.1002/vms3.724

PMID: 34989156

PMC: PMC8959255

Contributor: Levent Dirikolu

“Pharmacokinetic profiles of three dose rates of morphine sulfate following single intravenous, intramuscular, and subcutaneous administration in the goat”

Journal: Journal of Veterinary Pharmacology and Therapeutics

Date: September 7, 2021

DOI: 10.1111/jvp.13011

PMID: 34494277

Contributor: Levent Dirikolu

“Dexamethasone serum concentrations after intravenous administration in horses during race training”

Journal: Comparative Exercise Physiology

Date: April 12, 2021

DOI: 10.3920/cep200015

ISSNs: 1755-2540, 1755-2559

Contributor: Levent Dirikolu

“Liquid chromatography/tandem mass spectrometric analysis of penicillamine for its pharmacokinetic evaluation in dogs”

Journal: Toxicology Mechanisms and Methods

Date: September 10, 2020

DOI: 10.1080/15376516.2020.1814467

PMID: 32854553

Contributor: Levent Dirikolu

“Diffusion of enrofloxacin to pregnancy fluids and effects on fetal cartilage after intravenous administration to late pregnant mares”

Journal: Equine Veterinary Journal

Date: January 2, 2019

DOI: 10.1111/evj.13044

PMID: 30449030

Contributor: Levent Dirikolu

“The effect of sodium bicarbonate and validation of Beckman Coulter AU680 analyzers for measuring total carbon dioxide (TCO₂) concentrations in horse serum”

Journal: Veterinary Medicine and Science

Date: October 25, 2017

DOI: 10.1002/vms3.82

PMID: 29152319

PMC: PMC5677778

Contributor: Levent Dirikolu

“Characterization of long-term elution of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads in vitro by two distinct sample collection methods”

Journal: American Journal of Veterinary Research

Date: May 1, 2017

DOI: 10.2460/ajvr.78.5.618

PMID: 28441046

Contributor: Levent Dirikolu

“Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species”

Journal: Investigational New Drugs

Date: December 14, 2016

DOI: 10.1007/s10637-016-0414-z

PMID: 27975234

Contributor: Levent Dirikolu

“Elution of platinum from carboplatin-impregnated calcium sulfate hemihydrate beads in vitro”

Journal: American Journal of Veterinary Research

Date: November 1, 2016

DOI: 10.2460/ajvr.77.11.1252

PMID: 27805450

Contributor: Levent Dirikolu

“Evaluation of the effect of fluconazole on the pharmacokinetics of cyclosporin A in healthy dogs after a single dose and at steady-state”

Journal: Journal of Veterinary Pharmacology and Therapeutics

Date: September 1, 2016

DOI: 10.1111/jvp.12352

PMID: 27586063

Contributor: Levent Dirikolu

“Tear film concentrations of doxycycline following oral administration in ophthalmologically normal dogs”

Journal: Journal of the American Veterinary Medical Association

Date: September 1, 2016

DOI: 10.2460/javma.249.5.508

PMID: 27556265

Contributor: Levent Dirikolu

“Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells”

Journal: Veterinary Sciences

Date: April 24, 2015

DOI: [10.

Conclusion:

Dr. Levent Dirikolu is a highly qualified candidate for the Best Researcher Award. His extensive expertise in pharmacology and toxicology, demonstrated through impactful research and significant contributions to the field, makes him a standout nominee. His successful track record in securing research funding and the recognition he has received for his work reflect his excellence and dedication. By expanding his interdisciplinary collaborations and exploring emerging research areas, Dr. Dirikolu could further amplify his impact and continue to lead advancements in veterinary pharmacology.